Member Login

Editor-in-Chief Message

A New Feature For Dermatitis

The Dermatitis editorial office is pleased to announce the addition of a new publication category for our journal, entitled: “Images in Dermatitis”. This new publication category will be in addition to our existing categories of studies, reviews, editorials, abstracts, research letters and pearls & zebras.

Dermatology and especially the forensic art of diagnosing contact dermatitis is a “visual specialty”. We all recognize the central importance of the clinical examination to dermatologic diagnosis. The appearance, the morphology, the shape and distribution of lesions—these features leading to the diagnosis of contact dermatitis as well as other dermatologic diseases. The critical role of the physical examination, provides evidence to make a diagnosis visually, is part of the art of the study of contact dermatitis and related conditions and is shared by few other medical specialties.

This new publication category will be available in print and online issues of Dermatitis. The structure of “Images in Dermatitis” is similar to that of research letters or pearls & zebras (see below). This new category differs in that the image (or images) will be the centerpiece of the publication. The images can be a novel or an unusual presentation or a classic presentation of contact dermatitis, patch test reactions, atopic dermatitis, occupational dermatitis or drug-induced dermatitis. Similar to all submissions to the journal, manuscripts will undergo peer-review.

The purpose of this new publication category is to build an image database on our website, which can serve as an additional educational resource for our members. Manuscripts published as “Images in Dermatitis” can be cited by authors submitting articles to Dermatitis as well as other journals. Thus, “Images in Dermatitis” can contribute in a positive way to the impact factor of our Journal. It is also a celebration of the joy of the visual nature of our specialty. Instructions for this type of submission are summarized below and are also posted on our Journal’s website.

Instructions for Submitting a Manuscript

This feature is intended to provide a high-quality visual image of an interesting and unique dermatological observations related to Contact, Occupational, Atopic and Drug-Induced dermatitis. These include clinical images of skin diseases (i.e., photographs, photomicrographs, and other images) that enhance the understanding of cutaneous pathophysiology and improve clinicians' ability to diagnose and treat skin disorders.

Up to a 500-word description of the clinical issue, the patient's presentation and findings, and the image should be included. There should be no more than 2 images (figures), 5 references, and no more than 3 authors. Online supplementary material is not allowed.

For Dermatitis, the images should address one or more of the four major areas of focus of our Journal (Contact, Occupational, Atopic and Drug). The Images will be published in the print version of Dermatitis, and on the journal website as part of an image gallery.

If the patient(s) described in these manuscripts is identifiable, a Patient Permission form must be completed and signed by the patient(s) and submitted with the manuscript. Omitting data or making data less specific to de-identify patients is acceptable, but changing any such data is not acceptable.

We look forward to receiving your submissions for this new category of publication in Dermatitis.

Top Ten Scoring Altmetric Articles in Dermatitis from 2021

Our Dermatitis publisher’s annual report includes a measure of world-wide attention which our published articles receive from the preceding year. Articles receive an “Altmetric Score”, which represents a cumulative score that includes both academic (scholarly) as well as non-academic citations (social media mentions-such as newspapers, blogs, tweets). The higher the Altmetric score, the more attention the article is receiving. Altmetric scores of 15 or higher are considered to be strong “Attention-Getters”, which is great news for the Journal.

Here are the “Top 10” Dermatitis articles for 2021, ranked by their Altmetric scores (publication dates and Altmetric scores in parentheses):

  • Atopic Dermatitis Is Associated With Multiple Behavioral Problems in US Children and Adolescents (publication date: 4/9/2021; Altmetric score: 17)
  • Autoimmune Progesterone Dermatitis (publication date: 8/16/2021; Altmetric score: 15)
  • North American Contact Dermatitis Group Patch Test Results: 2017–2018 (publication date: 3/1/2021; Altmetric score: 12)
  • Impact of Gloves and Mask Use on Epidermal Barrier Function in Health Care Workers (publication date: 1/1/2021; Altmetric score: 10)
  • Reducing Discomfort and Irritation Related to Surgical Loop Masks in the Era of COVID-19: A Quality Improvement Initiative (publication date: 3/3/2021; Altmetric score: 10)
  • Systemic Treatment of Cutaneous Adverse Events After Immune Checkpoint Inhibitor Therapy (publication date: 8/16/2021; Altmetric score: 10)
  • The Burden of Coronavirus Disease 2019 and Its Complications in Patients With Atopic Dermatitis—A Nested Case-Control Study (publication date: 6/16/2021; Altmetric score: 10)
  • Anti-inflammatory Effect of Cannabidiol and Palmitoylethanolamide Containing Topical Formulation on Skin in a 12-O-Tetradecanoylphorbol-13-Acetate–Induced Dermatitis Model in Mice (publication date: 3/4/2021; Altmetric score: 9)
  • Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States (publication date: 9/27/2021 Altmetric score: 7)
  • Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Cutaneous Adverse Reactions: A Review (publication date: 4/12/2021; Altmetric score: 7)

It is noteworthy that all of the Dermatitis areas of interest (Contact, Occupational, Atopic and Drug) were represented in this “Attention-Getter” list, with Atopic dermatitis-related articles leading the way (three of the top 10 articles).

Congratulations to the authors of these articles!

Anthony A. Gaspari, MD
Dermatitis Editor-in-Chief


Cookie Notice

This website uses cookies to deliver to you the best experience possible on our website. By continuing to use this site, you are providing us with your consent to ensure you receive such an experience. View our privacy policy to learn more.